Baird analyst Catherine Ramsey Schulte raised the firm’s price target on Twist Bioscience (TWST) to $54 from $48 and keeps an Outperform rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback